🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Gerard M. Doherty

Mass General Brigham

ORCID: 0000-0002-7874-3766
MedicineSocial Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Oncogenic Mutations in PI3K/AKT/mTOR Pathway Effectors Associate with Worse Prognosis in BRAFV600E -Driven Papillary Thyroid Cancer Patients”.

Oncogenic Mutations in PI3K/AKT/mTOR Pathway Effectors Associate with Worse Prognosis in BRAFV600E -Driven Papillary Thyroid Cancer Patients

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0874
N/A
0DataRank · unranked
59 citations

Sara Ahmadi, Ellen Marqusee, Hannah Johnson, Matthew A. Nehs, Nancy L. Cho +7 more

Physician Perspectives of Overdiagnosis and Overtreatment of Low-Risk Papillary Thyroid Cancer in the US

JAMA Network Open(2022)10.1001/jamanetworkopen.2022.8722
N/A
0DataRank · unranked
44 citations

Megan C. Saucke, Kristin L. Long, Gerard M. Doherty, Susan C. Pitt, Priya H. Dedhia

Data from Oncogenic Mutations in PI3K/AKT/mTOR Pathway Effectors Associate with Worse Prognosis in BRAFV600E-Driven Papillary Thyroid Cancer Patients

(2023)10.1158/1078-0432.c.6530706
N/A
0DataRank · unranked
0 citations

Sara Ahmadi, Ellen Marqusee, Hannah Johnson, Matthew A. Nehs, Nancy L. Cho +7 more

Data from Oncogenic Mutations in PI3K/AKT/mTOR Pathway Effectors Associate with Worse Prognosis in BRAFV600E-Driven Papillary Thyroid Cancer Patients

(2023)10.1158/1078-0432.c.6530706.v1
N/A
0DataRank · unranked
0 citations

Sara Ahmadi, Ellen Marqusee, Hannah Johnson, Matthew A. Nehs, Nancy L. Cho +7 more